期刊文献+

瑞士乳杆菌和干酪乳杆菌纯种发酵绿豆乳培养基的研究 被引量:1

Optimization of Mungbean Milk Medium for Lactobacillus Helveticus and Lactobacillus Casei
原文传递
导出
摘要 以益生乳制品中选育的生长繁殖力强、发酵活力高的瑞士乳杆菌05-29和干酪乳杆菌05-211为试验菌株,采用层层筛选的方法优化发酵绿豆乳培养基,研究牛奶、大豆、蔗糖的添加量对瑞士乳杆菌05-29和干酪乳杆菌05-211纯种发酵绿豆乳活菌数和pH的影响;绿豆乳发酵培养基制备过程中均质压力、灭菌温度、护色剂添加量及色素添加量对发酵培养基色泽的影响。研究结果表明:添加牛奶23.75%,大豆乳5%,蔗糖4%纯种发酵6 h后,瑞士乳杆菌05-29达到4.5×108cfu/mL,pH 4.55;干酪乳杆菌07-211达到6.3×108cfu/mL,pH 4.69。采用20 MPa均质,95℃10 min灭菌,添加护色剂3‰,果绿0.010 g/kg,绿豆乳产品具有良好的外观颜色。 Lactobacillus helveticus 05-29 and Lactobacillus casei 05-211 were isolated from probiotic dairy products as the experiment strain.The prescription of mungbean milk was examined by layers of screening including the effect of the amount of pour milk,soybean milk and suger to the viable count and pH;Besides the protectivecoloration and toning are included in this research.The research results shows that the additive amount are pure milk 23.75%;soybean milk 5%;suger 4%.The viable count of Lactobacillus helveticus 05-29 is 4.5×108cfu/mL and pH is 4.55;the viable count of Lactobacillus casei 05-211 is 6.3×108cfu/mL and pH is 4.69.The processing technic of mungbean milk is 20 MPa homogeneity,95 ℃ 10 min sterilisatio,colour fixative 3‰,yellowish green 0.010 g/kg.The colour of mungbean milk is pleasing.
出处 《中国食品学报》 EI CAS CSCD 北大核心 2013年第6期117-122,共6页 Journal of Chinese Institute Of Food Science and Technology
基金 山东省科技发展计划项目(2010GG10048)
关键词 发酵绿豆乳 益生菌 瑞士乳杆菌 干酪乳杆菌 护色与调色 mungbean milk fermentation probiotics Lactobacillus helveticus Lactobacillus casei protectivecoloration and toning
  • 相关文献

参考文献8

二级参考文献63

共引文献77

同被引文献24

  • 1肖琳琳,董明盛.干酪乳杆菌KM-16的筛选及其降胆固醇活性研究[J].中国乳品工业,2003,31(6):7-10. 被引量:46
  • 2张百川,孟祥晨.益生菌抗肿瘤作用的分子机制的研究进展[J].现代食品科技,2005,21(4):88-89. 被引量:6
  • 3庄海霁,雷虹,张铁丹,周东坡,平文祥.副干酪乳杆菌的应用研究进展[J].生物技术通讯,2006,17(6):989-991. 被引量:24
  • 4沈中艳,赵述淼,梁运祥.耐胃肠道环境及肠道病原菌拮抗的猪源乳酸菌的分离与筛选[J].华中农业大学学报,2007,26(3):348-352. 被引量:18
  • 5雷虹,李秀凉,庄海霁,张铁丹,周东坡,平文祥.副干酪乳杆菌HD1.7产生抗菌物质的初步研究[J].工业微生物,2007,37(4):16-19. 被引量:21
  • 6布坎南·R·E,吉本斯·N·E.伯杰氏细菌鉴定手册(第八版)[M].第十六部分革兰氏阳性不生芽孢的杆状细菌,1984:797-808.
  • 7Sartor RB. Therapeutic manipulation of the enteric mi- eroflora in inflammatory bowel diseases;antibiotics,pro biotics,and prebiotics [J]. Gastroenterol,2004 (126) : 1620-1633.
  • 8Toshio Matsuzaki, Mineki Saito, Koichiro Usuku, et al. A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shi- rota in the treatment of HTLV-1 associated myelopa- thy/tropical spastic paraparesis [J]. Journal of the Neurological Sciences, 2005 (237) : 75 -81.
  • 9Takeshi Kobayashi, Takayuki Katagiri, et al. Protec- tive effects and mechanisms of a probiotic bacterium Lactobacillus rhamnosus against experimental Edward- siella tarda infection in tilapia [J]. Immunology and Immunopathology, 2006 ( 113 ) : 339-347.
  • 10Mortazavi S, Akhlaghi N. Salivary streptococcus mu- ans and Lactobacilli levels following probiotic cheese :onsumption in adults: A double blind randomized clincal trial[J]. J Res Med Sci,2012,17(1):57-66.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部